Description
+ Include: 11 videos + 1 pdf, size: 4.38 GB
+ Target Audience: oncologist
+ Sample video: contact me for sample video
+ Information:
Target Audience
Learning Objectives
At the conclusion of this activity, the learner will be able to:
- Identify the current indications for CAR T-cell therapy in cancer, including acute lymphoblastic leukemia and aggressive large B-cell lymphoma;
- State how to grade and manage CAR T-cell related toxicities including cytokine-release syndrome and neurologic toxicity;
- Identify novel targets and future directions in cellular therapy;
- Describe current approaches in nursing and supportive care for patients undergoing CAR T-cell therapy;
- Discuss how the uses of CAR T-cell therapy differ in pediatric and young adult patients.
+ Topics:
2196_UCMed_CarTCell_mailer_p12.pdf
Building a better CAR T-Cell.mp4
CAR T- Cell Therapy in Aggressive B-Cell Lymphoma- Clinical trial and Real World Experience.mp4
CAR T-Cell Failures- Mechanisms of Resistance Relapse.mp4
CAR T-Cell Therapy in Multiple Myeloma.mp4
CAR T-Cell Therapy in Pediatric AYA Acute Lymphoblastic Leukemia (ALL).mp4
Cellular Therapy in Solid Tumors.mp4
Cytokine Release Syndrome and Neurologic Toxicity Current Grading and Management 2.mp4
Cytokine Release Syndrome and Neurologic Toxicity Current Grading and Management.mp4
Overview of Immune Regulation and Chimeric Antigen Receptor (CAR) T-Cell Therapy 2.mp4
Overview of Immune Regulation and Chimeric Antigen Receptor (CAR) T-Cell Therapy.mp4
Patient Selection for CAR T- Cell Therapy.mp4
Reviews
There are no reviews yet.